Evidence map›Paper›PMID 37259363›Full record

ReviewPharmaceuticals (Basel, Switzerland)2023

Distinct Role of

Yali Niu, Guoheng Zhang, Xiaojia Sun, Shikun He, Guorui Dou

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Chemical Composition and Inhibitory Effect ofFoods (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Review
  6. Inulin andFrontiers in endocrinology · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yali NiuCollege of Life Sciences, Northwestern University, Xi'an 710069, China.
Guoheng ZhangDepartment of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Xiaojia SunDepartment of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Shikun HeDepartment of Ophthalmology, USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Guorui DouDepartment of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.ORCID 0000-0002-3107-1835
Xijing Hospital · CNUniversity of Southern California · US

Funding

clinical AFFMU foundation support 2021JSTS28National Natural Science Foundation of China 81970814, 81670863
6 · The paper itself

Abstract

Oxidative stress is an imbalance between the increased production of reactive species and reduced antioxidant activity, which can cause a variety of disturbances including ocular diseases.

Indexed as

age-related macular degenerationantioxidantdiabetic retinopathyhypertensive neuroretinopathyLycium barbarum polysaccharidesoxidative stressretinitis pigmentosa

Identifiers

PMID37259363
PMCPMC9966716
OpenAlexW4318706766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.